1. HOME
2. Research Insight
3. Linde Group (Germany) and Air Liquide (France) are the Leading Players in the Medical Gases and Equipment Market

The global medical gases and equipment market is projected to reach USD 20.0 billion by 2023 from USD 14.0 billion in 2018, at a CAGR of 6.2%. Rising aging population, increasing prevalence of respiratory diseases like asthma and chronic obstructive pulmonary disorder (COPD) due to changing lifestyles, rapid urbanization, high prevalence of tobacco smoking, and increasing incidences of preterm births are expected to drive the growth of the medical gases and equipment market across the globe. Technological advancements, increasing demand for home care therapeutics, and market expansion in emerging countries across APAC and Latin America have opened new avenues for the medical gases and equipment market. However, there are certain challenges and restraints for the growth of this market, such as changes in medical gas calibration standards, global shortage of helium, declining federal reimbursements for respiratory therapies, and lack of awareness and untreated population.

Linde Group (Germany) and Air Liquide (France), Air Products and Chemicals, Inc. (US), Praxair, Inc. (US), Taiyo Nippon Sanso Corporation (Japan), Atlas Copco (Sweden), GCE Holding (Sweden), Messer Group (Germany), SOL SpA (Italy), Rotarex S.A. (Luxembourg), SCI Analytical (US) and Amico Corporation (Canada) are some key players in this market. These companies are focusing on increasing their presence in the high-growth markets through both organic as well as inorganic growth strategies such as product launches, approvals & enhancements; expansion; agreements, collaboration & partnerships; and acquisition.

To know about the assumptions considered for the study download the pdf brochure

Linde Group is the leading player in the medical gases and equipment market with a presence of more than 100 years in the gases and engineering industry. The company has a strong presence across the Americas, Asia-Pacific, and EMEA. The company focuses on improving its global presence through inorganic strategies such as acquisitions, agreements and partnerships with other small players and to strengthen its product portfolio in the market. The company has a well-balanced portfolio for both the hospital care and home healthcare markets. The company thus has a good growth opportunity, especially due to the rise in patient in home care settings rather than in hospitals. The company also focuses on strengthening its position by entering into emerging countries to capture untapped medical gasses and equipment market. For instance, Linde started construction of new air separation unit (ASU) in Tanjung Kidurong, East Malaysia in 2017.

Air Liquide is the second-largest player in the global medical gases and equipment market in 2018. The healthcare division of the company caters to approximately 15,000 hospitals and clinics, and 1.5 million patients at home. Company’s leading position in this market is attributed to its wide product portfolio, which includes pure gases, specialty gases, and research gases which include cryobiology and hyperbaric oxygen solutions. The company has a wide geographic presence spanning Europe, North America, Latin America, Africa, the Middle East, and the Asia Pacific. In order to sustain its leading position in the market, the company focuses on partnerships and collaborations with other players in this market. Air Liquide also focuses on geographic expansion. In line with this, the firm has opened new facilities in the US and China in 2018 and 2016 respectively.

Related Reports:

Medical Gas and Equipment Market by Type (Oxygen, Nitrous Oxide, Carbon Dioxide, Gas Mixture, Vacuum System, Manifold, VIPR, Hose) Application (Respiratory, Anesthesia, Medical Imaging, Cryosurgery) End User (Hospital, Home Healthcare) - Forecast to 2023

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]